LYTIR

Insider · SEC Form 4 · EVP, Chief Scientific Ofc, COO

Jim Wassil

Filed with the SEC as Wassil Jim; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $2.5M of PCVX. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $2.5M in total.Jul: Insider sales $127KAug: Insider sales $121KSep: Insider sales $376KOct: Insider sales $1.7MNov: Insider sales $137KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $2.5M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. PCVXSold: Vaxcyte, Inc. Nov 2, 2026 2,250 shares filed Nov 4, 2026 2 transactions 10b5-1 plan filing $137K
  2. PCVXSold: Vaxcyte, Inc. Oct 5, 2026 18,000 shares filed Oct 7, 2026 145,435 shares held directly after, as filed 10b5-1 plan filing $1.6M
  3. PCVXSold: Vaxcyte, Inc. Oct 1, 2026 2,250 shares filed Oct 2, 2026 2 transactions 10b5-1 plan filing $128K
  4. PCVXSold: Vaxcyte, Inc. Sep 9, 2026 1,334 shares filed Sep 9, 2026 145,435 shares held directly after, as filed 10b5-1 plan filing $79K
  5. PCVXSold: Vaxcyte, Inc. Sep 4, 2026 1,381 shares filed Sep 9, 2026 152,228 shares held directly after, as filed 10b5-1 plan filing $84K
  6. PCVXSold: Vaxcyte, Inc. Sep 1, 2026 3,477 shares filed Sep 2, 2026 4 transactions 10b5-1 plan filing $212K
  7. PCVXSold: Vaxcyte, Inc. Aug 3, 2026 2,250 shares filed Aug 5, 2026 2 transactions 10b5-1 plan filing $121K
  8. PCVXSold: Vaxcyte, Inc. Jul 1, 2026 2,250 shares filed Jul 6, 2026 3 transactions 10b5-1 plan filing $127K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • PCVX: option exercise or conversion (code M), 6 entries, Jul 1 to Nov 2, 2026
  • PCVX: shares withheld for tax or exercise price (code F), 3 entries, Aug 31 to Sep 8, 2026
Code F
Shares paid to, or withheld by, the company to cover an exercise price or the tax due on an award.
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.